CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

List of SGT cannabinoids

Wikimedia list article

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionMar 24, 2026
Entity authorityQ135350395 ↗
Source-derived summary

Many synthetic cannabinoids were designed by Stargate International, a now defunct New Zealand company in the 2000s and 2010s, and feature an alphanumeric code beginning with the prefix "SGT". PB-22 (SGT-21) is credited with being the first synthetic cannabinoid to feature a quinoline substructure with an ester linker at the indole 3-position. The mainly N-cumyl-indazole-3-carboxamide derivatives are best known. Many SGT compounds are banned as designer drugs in various jurisdictions, such as Japan.

Editorial summary

“List of SGT cannabinoids” enters the record as wikimedia list article. Crown Archives preserves that source wording while asking what List, cannabinoids and Wikimedia can confirm, complicate or overturn.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current 73-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its strongest next move is a source search built around List, cannabinoids and Wikimedia.
Editorial analysis

Why this record matters

“List of SGT cannabinoids” is worth following because a concise public description often conceals a longer documentary argument. Here, List, cannabinoids and Wikimedia provides the most credible route into that argument.

Evidence profile

Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Mar 24, 2026. The linked authority identifier is Q135350395. None of the 0 selected statements returned an explicit reference.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “List of SGT cannabinoids”, its source revision and the description used here.
  2. Expand the search: follow List of SGT cannabinoids primary sources, List of SGT cannabinoids archive and List research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “List of SGT cannabinoids”?
  2. What terminology or title could unlock a more precise catalogue search?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “List of SGT cannabinoids” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.